Biocon Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOCON PHARMA, and what generic and branded alternatives to BIOCON PHARMA drugs are available?
BIOCON PHARMA has ten approved drugs.
Summary for Biocon Pharma
US Patents: | 0 |
Tradenames: | 10 |
Ingredients: | 10 |
NDAs: | 10 |
Patent Litigation for Biocon Pharma: | See patent lawsuits for Biocon Pharma |
PTAB Cases with Biocon Pharma as petitioner: | See PTAB cases with Biocon Pharma as petitioner |
Drugs and US Patents for Biocon Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocon Pharma | PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 211090-001 | May 25, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Biocon Pharma | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207752-001 | Oct 31, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Biocon Pharma | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 216436-001 | Nov 23, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Biocon Pharma | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209639-002 | Mar 13, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Biocon Pharma | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 209869-001 | Apr 13, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.